Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Fatigue. Found 20 abstracts

Steffen LE, Cheavens JS, Vowles KE, Gabbard J, Nguyen H, Gan GN, Edelman MJ, Smith BW. Hope-related goal cognitions and daily experiences of fatigue, pain, and functional concern among lung cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2019 Jun;.   PMCID: PMC6885110
Moore KN, Martin LP, O'Malley DM, Matulonis UA, Konner JA, Perez RP, Bauer TM, Ruiz-Soto R, Birrer MJ. Safety and Activity of Mirvetuximab Soravtansine (IMGN853), a Folate Receptor Alpha-Targeting Antibody-Drug Conjugate, in Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer: A Phase I Expansion Study. J Clin Oncol. 2017 Apr;35(10):1112-8.   PMCID: PMC5559878
Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, Mohr D, Palesh OG, Peppone LJ, Piper BF, Scarpato J, Smith T, Sprod LK, Miller SM. Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis. JAMA Oncol. 2017 Jul;3(7):961-8.   PMCID: PMC5557289
Berger AM, Mooney K, Alvarez-Perez A, Breitbart WS, Carpenter KM, Cella D, Cleeland C, Dotan E, Eisenberger MA, Escalante CP, Jacobsen PB, Jankowski C, LeBlanc T, Ligibel JA, Loggers ET, Mandrell B, Murphy BA, Palesh O, Pirl WF, Plaxe SC, Riba MB, Rugo HS, Salvador C, Wagner LI, Wagner-Johnston ND, Zachariah FJ, Bergman MA, Smith C, National comprehensive cancer n. Cancer-Related Fatigue, Version 2.2015. J Natl Compr Canc Netw. 2015 Aug;13(8):1012-39.   PMCID: PMC5499710
Ream E, Gargaro G, Barsevick A, Richardson A. Management of cancer-related fatigue during chemotherapy through telephone motivational interviewing: Modeling and randomized exploratory trial. Patient education and counseling. 2015 Feb;98(2):199-206.
Vijayvergia N, Shah PC, Denlinger CS. Survivorship in Non-Small Cell Lung Cancer: Challenges Faced and Steps Forward. J Natl Compr Canc Netw. 2015 Sep;13(9):1151-61.
Mateo J, Berlin J, de Bono JS, Cohen RB, Keedy V, Mugundu G, Zhang L, Abbattista A, Davis C, Gallo Stampino C, Borghaei H. A first-in-human study of the anti-alpha5beta1 integrin monoclonal antibody PF-04605412 administered intravenously to patients with advanced solid tumors. Cancer Chemother Pharmacol. 2014 Nov;74(5):1039-46.   PMCID: Pmc4209234
Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity. J Clin Oncol. 2014 Jun 20;32(18):1895-901.   PMCID: PMC4050203
Cohen RB, Aamdal S, Nyakas M, Cavallin M, Green D, Learoyd M, Smith I, Kurzrock R. A phase I dose-finding, safety and tolerability study of AZD8330 in patients with advanced malignancies. Eur J Cancer. 2013 May;49(7):1521-9.   PMCID: *
Barsevick A, Frost M, Zwinderman A, Hall P, Halyard M, Geneqol Consortium. I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2010 Dec;19(10):1419-27.   PMCID: PMC3031957
Barsevick AM, Cleeland CS, Manning DC, O'Mara AM, Reeve BB, Scott JA, Sloan JA, Ascpro. ASCPRO recommendations for the assessment of fatigue as an outcome in clinical trials. J Pain Symptom Manage. 2010 Jun;39(6):1086-99.   PMCID: PMC2909842
Barsevick AM, Whitmer K, Sweeney C, Nail LM. A pilot study examining energy conservation for cancer treatment-related fatigue. Cancer nursing. 2002 Oct;25(5):333-41.
Hudes G, Haas N, Yeslow G, Gillon T, Gunnarsson PO, Ellman M, Nordle O, Eriksson B, Miller L, Cisar L, Kopreski M, Viaro D, Hartley-Asp B. Phase I clinical and pharmacologic trial of intravenous estramustine phosphate. J Clin Oncol. 2002 Feb 15;20(4):1115-27.
Barsevick AM. From research to clinical practice: assessment and management of cancer fatigue. Cancer fatigue assessment tool.... commentary on Mendoza T, Wang XS, Cleeland CS, Morrissey M, Johnson BA, Wendt JK et al. (1998). The rapid assessment of fatigue severity in cancer patients: use of the brief fatigue inventory. Cancer, 85, 1186-1196. Clinical Journal of Oncology Nursing. 2001 Jan;5(1):39.
Barsevick AM, Whitmer K, Walker L. In their own words: using the Common Sense Model to analyze patient descriptions of cancer-related fatigue. Oncology Nursing Forum. 2001 Oct;28(9):1363-9.
Whitmer K, Barsevick A. Patient resources for cancer-related fatigue. Cancer Pract. 2001 Nov;9(6):311-3.
Schwartz AL, Nail LM, Chen S, Meek P, Barsevick AM, King ME, Jones LS. Fatigue patterns observed in patients receiving chemotherapy and radiotherapy. Cancer Invest. 2000 Jan;18(1):11-9.
Barsevick AM. How patients cope with fatigue during cancer treatment: current scientific understanding. Developments in Supportive Cancer Care. 1998 Jan;2(3):83-6.
Jakubek PR, Barsevick AM. Practice corner. Practice tips from Fox Chase Cancer Center, Philadelphia, PA... Use of a daily journal for fatigue management. Oncology Nursing Forum. 1998 Jan;25(6):987-9.
O'Dwyer PJ, Laub PB, DeMaria D, Qian M, Reilly D, Giantonio B, Johnston AL, Wu EY, Bauman L, Clendeninn NJ, Gallo JM. Phase I trial of the thymidylate synthase inhibitor AG331 as a 5-day continuous infusion. Clin Cancer Res. 1996 Oct;2(10):1685-92.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Fatigue

Fatigue Neoplasms Female Male Aged complications drug therapy adverse effects etiology Adult chemically induced Treatment Outcome Human therapeutic use Middle Aged Nausea Middle Age Cancer Patients metabolism therapy pathology 80 and over Aged pharmacokinetics drug effects antagonists & inhibitors analysis Drug Administration Schedule Pain Intravenous Infusions Metabolic Clearance Rate Hypotension Non-US Gov't Support psychology Drug Dose-Response Relationship Area Under Curve methods US Gov't Support-PHS Vomiting Disease-Free Survival diagnosis Antineoplastic Agents Coping administration & dosage Neoplasm Drug Resistance Adolescent chemistry Quality of Life Diarrhea ev [Evaluation] physiopathology Adjuvant Chemotherapy Monoclonal Antibodies-Humanized Audiorecording Exercise Therapy Secondary Analysis Internet Cancer Descriptive Statistics Health Behavior Socioeconomic Factors Acne Vulgaris Fever Affect Pneumonectomy epidemiology Glucocorticoids Exercise Gene Expression Profiling Research Fear Guilt Dextroamphetamine Chemotherapy Cisplatin Hope Clinical Assessment Tools Transitional Cell Carcinoma Fallopian Tube Neoplasms Filgrastim Information Services mortality Granulocyte Colony-Stimulating Factor Lung cancer Non-Small-Cell Lung Carcinoma Mental Processes Clinical Trials as Topic use Protective Agents dosage Tumor Biomarkers Theoretical Nursing Models MAP Kinase Kinase 2 Prostatic Neoplasms Young Adult Survivors et [Etiology] Liver Prospective Studies genetics Focus Groups Energy Metabolism Patient Attitudes Analysis of Variance therapeutic adverse Dermatitis Radiotherapy Genetic Polymorphism Convenience Sample Urinary Bladder Neoplasms Flushing effects Methotrexate US Gov't Support-Non-PHS Recombinant Proteins Self Care Bilirubin Patient Education Retreatment United States Protein Kinase Inhibitors Serotonin Uptake Inhibitors immunology Sleep Antineoplastic Combined Chemotherapy Protocols Methylphenidate Platinum Compounds radiotherapy Continuing (Credit) Education di [Diagnosis] Vinblastine Cytokines Qualitative Studies Wakefulness-Promoting Agents Paroxetine th [Therapy] Information Resources Oncologic Nursing Psychological intervention Central Nervous System Stimulants Motor Activity Diaries Dexmethylphenidate Hydrochloride Alanine Transaminase Patients Exploratory Research Benzhydryl Compounds Integrin alpha5beta1 United States Food and Drug Administration Psychotherapy
Last updated on Friday, January 03, 2020